Torrent Pharmaceuticals (India) Performance
| TORNTPHARM | 3,224 1.10 0.03% |
The entity has a beta of 0.25, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Torrent Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Torrent Pharmaceuticals is expected to be smaller as well. At this point, Torrent Pharmaceuticals has a negative expected return of -0.11%. Please make sure to validate Torrent Pharmaceuticals' maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Torrent Pharmaceuticals performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Torrent Pharmaceuticals Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
Forward Dividend Yield 0.0087 | Payout Ratio 0.5528 | Last Split Factor 2:1 | Forward Dividend Rate 28 | Ex Dividend Date 2024-06-21 |
1 | Stocks To Watch HDFC, IT stocks, Torrent Pharma, Ola Electric, Adani Green - Business Standard | 09/26/2024 |
2 | Indias Torrent Pharma misses Q2 profit view after closure of insulin unit - Reuters India | 10/25/2024 |
3 | Torrent Pharma Share Price Today Live NSEBSE -Torrent Pharmaceuticals Ltd. Stock Price, Key Insights and Summary - ET Now | 11/14/2024 |
4 | Torrent Pharma shares gain on USFDAs VAI tag to Pithampur facility - Business Standard | 11/21/2024 |
| Begin Period Cash Flow | 5.1 B | |
| Free Cash Flow | 28.3 B |
Torrent |
Torrent Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 348,515 in Torrent Pharmaceuticals Limited on August 30, 2024 and sell it today you would lose (26,070) from holding Torrent Pharmaceuticals Limited or give up 7.48% of portfolio value over 90 days. Torrent Pharmaceuticals Limited is generating negative expected returns and assumes 1.586% volatility on return distribution over the 90 days horizon. Simply put, 14% of stocks are less volatile than Torrent, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Torrent Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Torrent Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Torrent Pharmaceuticals Limited, and traders can use it to determine the average amount a Torrent Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.07
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TORNTPHARM |
Estimated Market Risk
| 1.59 actual daily | 14 86% of assets are more volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Torrent Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Torrent Pharmaceuticals by adding Torrent Pharmaceuticals to a well-diversified portfolio.
Torrent Pharmaceuticals Fundamentals Growth
Torrent Stock prices reflect investors' perceptions of the future prospects and financial health of Torrent Pharmaceuticals, and Torrent Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Torrent Stock performance.
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 1.11 T | ||||
| Shares Outstanding | 338.44 M | ||||
| Price To Book | 14.55 X | ||||
| Price To Sales | 9.73 X | ||||
| Revenue | 106.05 B | ||||
| Gross Profit | 60.66 B | ||||
| EBITDA | 35.01 B | ||||
| Net Income | 16.56 B | ||||
| Cash And Equivalents | 379.8 M | ||||
| Total Debt | 40.22 B | ||||
| Book Value Per Share | 221.48 X | ||||
| Cash Flow From Operations | 32.66 B | ||||
| Earnings Per Share | 53.20 X | ||||
| Total Asset | 150.61 B | ||||
| Retained Earnings | 39.42 B | ||||
About Torrent Pharmaceuticals Performance
By evaluating Torrent Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Torrent Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Torrent Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Torrent Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Torrent Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange.Things to note about Torrent Pharmaceuticals performance evaluation
Checking the ongoing alerts about Torrent Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Torrent Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Torrent Pharmaceuticals generated a negative expected return over the last 90 days | |
| Torrent Pharmaceuticals is unlikely to experience financial distress in the next 2 years | |
| About 70.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Torrent Pharma shares gain on USFDAs VAI tag to Pithampur facility - Business Standard |
- Analyzing Torrent Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Torrent Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Torrent Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Torrent Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Torrent Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Torrent Pharmaceuticals' stock. These opinions can provide insight into Torrent Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Torrent Stock analysis
When running Torrent Pharmaceuticals' price analysis, check to measure Torrent Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Torrent Pharmaceuticals is operating at the current time. Most of Torrent Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Torrent Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Torrent Pharmaceuticals' price. Additionally, you may evaluate how the addition of Torrent Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges |